Talk:Pre-exposure prophylaxis for HIV prevention

message: This entry is surprisingly out of date; PrEP is not longer experimental, having been approved by the FDA in 2012; several studies have further attested to its effectiveness; other studies have shown no increase in risky behavior; but the newest studies cited in the article are well out of date. Can someone help?
Dpmath (talk) 05:41, 24 April 2014 (UTC)
replies: text: I just updated it a bit.  Blue Rasberry (talk) 23:42, 28 December 2014 (UTC)
thread_title:  OUT OF DATE 

message: Might be worth noting that this technique is also in use when there is a risk of transmitting a disease during a medical procedure. Specifically, its use in dentistry. Take a look here. Muuon (talk) 08:11, 19 November 2007 (UTC)
thread_title:  Use in dentistry 

message: Agreed with your edits to make page more patient-friendly and up-to-date, as well as to remove much extraneous or redundant info. I would consider keeping the intro shorter and expanding on details in the body (ie discuss Truvada, its formula, and how to use it further elsewhere). Some medical jargon still exist on the page (ie serodiscordant can be changed to something like "mixed HIV-status couples"). The current events info (usage, research, etc) is fantastic. Well-done also on keeping the voice neutral.
Vhwang8 (talk) 02:58, 12 December 2017 (UTC)
thread_title:  Peer Review 

message: This article has a research table which seeks to summarize some research on prep. I am not sure what information should be contained in such a table. There is limited space. Additional information which I would like to see is number of study participants and dates of the study. If any information is added then probably something should be removed. There are not really standards in Wikipedia for deciding what information is most important about clinical trials.  Blue Rasberry (talk) 13:19, 6 February 2017 (UTC)
thread_title:  Research table 

message: I started it at HPTN 083.  Blue Rasberry (talk) 13:19, 6 February 2017 (UTC)
thread_title: Related article about new prep trial

message: Unfortunately I don't have the skills to edit the map, but Iceland has approved PrEP and started distributing it in July this year.
See this link
Argamea (talk) 15:04, 19 September 2018 (UTC)
thread_title:  Iceland has approved PrEP 

message: Why is "adherence" a parenthetical after "Number of people who took medication." That seems like a pretty misleading description of adherence. Roboraptor3000 (talk) 16:46, 18 May 2020 (UTC)
replies: text: The number of patients who actually take a prescribed medication is called "adherence". Ruslik_Zero 19:38, 18 May 2020 (UTC)
thread_title:  Adherence 

message: Do the group’s edits improve the article as described in the Wikipedia peer review “Guiding framework”? Has the group achieved its overall goals for improvement?
Yes, I would say that the group’s edits have improved the article. The sections added under the “Medical Uses” section was an important addition, particularly the paragraph describing the dosing regimen and comparison between PrEP and ED-PrEP. This section definitely achieved the group’s goal to include information about how and when to use PrEP, and the language used was appropriate and easy to understand. They were also careful to not use medical language and did not refer to those taking PrEP as “patients,” which was appropriate. I appreciated the section “Availability and Pricing in the United States,” although I thought that the information added to this section aligned more with your goal for the “Politics and Culture” section, but you got the information into the article and it is definitely a valuable addition. I cannot see any evidence of plagiarism, and the group has included appropriate citations and references throughout the new additions to their article. Gmackey18 (talk) 21:03, 3 August 2020 (UTC)
thread_title:  Foundations II 2020 Group 24 Peer Review  

message: There have been a handful of studies into using injectable cabotegravir for long-acting pre-exposure prophylaxis; I can't do so right now, but it would be good to incorporate that into this article, as an update to the "Emerging treatments". Here's a couple of news articles on the topic
* 
* 
— OwenBlacker (he/him; Talk; please  me in replies) 14:40, 11 November 2020 (UTC)
thread_title:  Cabotegravir as PrEP 

message: As mentioned above several years ago, this article is in theory a generic concept about pre-exposure prophylaxis, as it can apply to many diseases and infections, such as malaria.
However the vast vast majority of its contents are actually talking only about a specific usage of PrEP – for HIV prevention. This is one of the most notable and discussed uses of PrEP, but it shouldn't take over the entire article. Since HIV PrEP is clearly notable in its own right, I propose the article be split into HIV pre-exposure prophylaxis (name is only a suggestion, not set in stone), and Pre-exposure prophylaxis. 
The ideal way of doing this would be to do a reverse split, and move this article to HIV pre-exposure prophylaxis (because nearly all of its content is about this topic specifically) and spin the much smaller content about PrEP as a general medical practice out into a separate article with the current name. i.e.
* Pre-exposure prophylaxis is moved to HIV pre-exposure prophylaxis (or similar name)
* New article usurps the title Pre-exposure prophylaxis dealing with it as a general medical topic, the way we have articles on antibiotics, cauterization etc., which are not focused on their use for a specific illness or condition. - Estoy Aquí (talk) 14:08, 31 December 2022 (UTC)
replies: text: *Support although the article is currently not that long, these are independently notable concepts that could be covered in enough detail to warrant their own individual articles. Tom (LT) (talk) 06:18, 13 May 2023 (UTC)

text: Support When people say PrEP, 9 times out of 10, they are referring to it in the context of HIV/AIDS. PrEP in other contexts deserves a separate article. 2013creek (talk) 19:26, 19 June 2023 (UTC)
thread_title:  Proposed split 

message: Good article about PrEP but couldn't help but notice that in the line "As of 2018, numerous countries have approved the use of PrEP for HIV/AIDS prevention, including the United States, South Korea, France, Norway, Australia, Israel, Canada, Kenya, South Africa, Peru, Thailand, the European Union and Taiwan" the EU is named as a country, which it is not as it's a supranational organisation of different countries of which France (a country that's also listed) is one of it's founding members. Regarding the admission of new pharmaceutical products/medicine or it's (new) uses, as I understand it (although I'm not an expert) the member states' own procedures and regulations are still in effect besides the route through the EU and it's European Medicines Agency. Thoughts? Jaap-073 (talk) 14:39, 4 June 2024 (UTC)
thread_title:  Approval for use (numerous countries, EU?)